Biogen, Eisai’s lecanemab gets Alzheimer’s nod, but how successful it will be is uncertain
agrobacter/iStock by way of Getty Photographs The US FDA on Friday granted accelerated approval to Biogen (NASDAQ:BIIB) and Eisai's (OTCPK:ESALY) ...
agrobacter/iStock by way of Getty Photographs The US FDA on Friday granted accelerated approval to Biogen (NASDAQ:BIIB) and Eisai's (OTCPK:ESALY) ...